| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Opus Genetics, Inc. | Chief Operating Officer | Common Stock | 54.5K | $62.7K | $1.15 | Mar 13, 2025 | Direct |
| Opus Genetics, Inc. | Chief Operating Officer | Employee Stock Option (right to buy) | 52.5K | Mar 13, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IRD | Opus Genetics, Inc. | Mar 13, 2025 | 2 | $0 | 4 | Mar 17, 2025 | Chief Operating Officer |
| OCUP | Ocuphire Pharma, Inc. | Mar 21, 2024 | 1 | $4.1K | 4 | Mar 25, 2024 | Chief Operating Officer |
| OCUP | Ocuphire Pharma, Inc. | Nov 27, 2023 | 1 | $0 | 4 | Nov 27, 2023 | Chief Operating Officer |
| OCUP | Ocuphire Pharma, Inc. | Nov 27, 2023 | 0 | $0 | 3 | Nov 27, 2023 | Chief Operating Officer |